White House Reiterates Confidence In FDA Expertise, Independence With J&J Vaccine Pause

Not only did White House and other officials support the recommendation, but also made clear they had no advance notice of it.

White House and other officials affirmed their confidence in the US Food and Drug Administration and the Centers for Disease Control and Prevention after the agencies caused a stir by recommending a pause in administration of the Janssen Biotech Inc. coronavirus vaccine because of concerns about rare blood clots.

FDA and CDC officials announced 13 April that six cases of cerebral venous sinus thrombosis in combination with thrombocytopenia had...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet